JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Financials | 14% |
| 3 | Technology | 12.71% |
| 4 | Healthcare | 9.7% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3001
Galicia Financial Group
GGAL
$5.76B
| $2.82M | ﹤0.01% |
85,481
-35,356
| -29% | -$1.82M |
2017 Q2
4 quarters
|
|
3002
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$18B
| $2.82M | ﹤0.01% |
27,764
+2,679
| +11% | +$272K |
2013 Q2
20 quarters
|
|
|
CPRX
3003
DELISTED
Catalyst Pharmaceutical
CPRX
| $2.82M | ﹤0.01% |
902,388
-250,665
| -22% | -$760K |
2017 Q1
5 quarters
|
|
3004
PUT
Best Buy
BBY
$18.4B
| $2.81M | ﹤0.01% |
37,700
| – | – |
2018 Q1
1 quarter
|
|
3005
Waterstone Financial
WSBF
$358M
| $2.81M | ﹤0.01% |
164,841
-961
| -0.6% | -$16.8K |
2015 Q3
11 quarters
|
|
|
PMT
3006
PennyMac Mortgage Investment
PMT
$680M
| $2.8M | ﹤0.01% |
147,353
+38,148
| +35% | +$699K |
2017 Q4
2 quarters
|
|
3007
Central Garden & Pet Co
CENT
$2.49B
| $2.79M | ﹤0.01% |
80,215
+18,036
| +29% | +$590K |
2015 Q4
10 quarters
|
|
3008
Gran Tierra Energy
GTE
$369M
| $2.79M | ﹤0.01% |
80,788
-42,215
| -34% | -$1.35M |
2017 Q2
4 quarters
|
|
|
STI
3009
PUT
DELISTED
SunTrust Banks, Inc.
STI
| $2.79M | ﹤0.01% |
42,200
| – | – |
2017 Q2
4 quarters
|
|
3010
AMERISAFE
AMSF
$437M
| $2.79M | ﹤0.01% |
48,236
+8,184
| +20% | +$478K |
2013 Q2
20 quarters
|
|
3011
CarGurus
CARG
$2.67B
| $2.78M | ﹤0.01% |
79,915
+43,793
| +121% | +$1.47M |
2017 Q4
2 quarters
|
|
|
ONC
3012
CALL
BeOne Medicines Ltd
ONC
$40.5B
| $2.77M | ﹤0.01% |
+18,000
| New | +$3.21M |
2018 Q2
0 quarters
|
|
|
ONC
3013
PUT
BeOne Medicines Ltd
ONC
$40.5B
| $2.77M | ﹤0.01% |
+18,000
| New | +$3.21M |
2018 Q2
0 quarters
|
|
|
ETFC
3014
CALL
DELISTED
E*Trade Financial Corporation
ETFC
| $2.75M | ﹤0.01% |
45,000
| – | – |
2017 Q3
3 quarters
|
|
|
ETFC
3015
PUT
DELISTED
E*Trade Financial Corporation
ETFC
| $2.75M | ﹤0.01% |
45,000
-121,800
| -73% | -$7.54M |
2017 Q4
2 quarters
|
|
|
ACHN
3016
DELISTED
Achillion Pharmaceuticals
ACHN
| $2.75M | ﹤0.01% |
970,168
-64,465
| -6% | -$220K |
2014 Q3
15 quarters
|
|
3017
CALL
Aon
AON
$57.2B
| $2.74M | ﹤0.01% |
+20,000
| New | +$2.82M |
2018 Q2
0 quarters
|
|
|
3018
PUT
Aon
AON
$57.2B
| $2.74M | ﹤0.01% |
+20,000
| New | +$2.82M |
2018 Q2
0 quarters
|
|
3019
Healthcare Services Group
HCSG
$1.43B
| $2.73M | ﹤0.01% |
63,312
+6,063
| +11% | +$241K |
2013 Q2
20 quarters
|
|
3020
Cable One
CABO
$69.3M
| $2.73M | ﹤0.01% |
3,724
+950
| +34% | +$645K |
2015 Q3
11 quarters
|
|
3021
Onto Innovation
ONTO
$16.1B
| $2.73M | ﹤0.01% |
77,110
-215,759
| -74% | -$7.39M |
2013 Q2
20 quarters
|
|
|
SWCH
3022
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $2.72M | ﹤0.01% |
223,513
+112,863
| +102% | +$1.54M |
2017 Q4
2 quarters
|
|
3023
CALL
Nutrien
NTR
$33.4B
| $2.72M | ﹤0.01% |
+50,000
| New | +$2.48M |
2018 Q2
0 quarters
|
|
3024
Greenlight Captial
GLRE
$481M
| $2.7M | ﹤0.01% |
190,438
+178,517
| +1,498% | +$2.72M |
2017 Q4
2 quarters
|
|
3025
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.39B
| $2.7M | ﹤0.01% |
70,668
-10,357
| -13% | -$382K |
2016 Q4
6 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.